(NASDAQ: QTRX) Quanterix's forecast annual revenue growth rate of 15.29% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.07%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.78%.
Quanterix's revenue in 2026 is $138,897,000.On average, 6 Wall Street analysts forecast QTRX's revenue for 2026 to be $8,181,637,643, with the lowest QTRX revenue forecast at $7,820,199,835, and the highest QTRX revenue forecast at $8,462,808,093. On average, 6 Wall Street analysts forecast QTRX's revenue for 2027 to be $8,984,780,615, with the lowest QTRX revenue forecast at $8,445,909,702, and the highest QTRX revenue forecast at $9,409,117,989.
In 2028, QTRX is forecast to generate $10,039,991,253 in revenue, with the lowest revenue forecast at $9,292,237,451 and the highest revenue forecast at $10,720,151,491.